XCath announced the completion of the world's first remote robotic mechanical thrombectomy in a stroke patient in Panama. Transradial access failed to match transfemoral access for diagnostic cerebral ...

Lawrenceville, Ga.-based Northside Hospital Gwinnett is the first hospital in Georgia, and the first in the U.S. outside a clinical trial, to use Emboline’s embolic protection catheter during a ...

Two new randomized trials are reopening the question of whether thrombectomy may benefit selected patients with acute ischemic stroke caused by distal or medium vessel occlusions, a population in ...

CHOICE2 randomized 400 patients across 14 Spanish centers to thrombectomy alone versus thrombectomy plus intraarterial alteplase, with 90-day mRS as the primary endpoint. Excellent outcomes (mRS 0–1) ...

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary ...

Penumbra has rolled out its first new system since Boston Scientific announced plans to acquire the company in a $14.5 billion cash and stock deal. The company has launched its Lightning Flash 3.0 ...

Alongside the deal announcement, Penumbra also disclosed preliminary financial details that helped underpin the stock’s premarket strength. The company reported that its fourth-quarter 2025 revenue ...

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire California-based Penumbra. The company started off the week presenting at the ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system. Inquis Medical, Inc., a privately held medical technology company dedicated to ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its commercial rollout with its first procedures. At the same time, the medtech ...